Co-promotion agreement for Exenatide once-weeklyCo-Promotion Agreement • November 8th, 2022 • New York
Contract Type FiledNovember 8th, 2022 JurisdictionFirst amendment to development, supply, manufacturing, licensing, promotion, and loan agreement for Exenatide once-weekly Development, supply, manufacturing, licensing, promotion, and loan agreement for Exenatide once-weekly (terminated)
Co-promotion agreement for Exenatide once-weeklyCo-Promotion Agreement • January 28th, 2022 • New York
Contract Type FiledJanuary 28th, 2022 JurisdictionFirst amendment to development, supply, manufacturing, licensing, promotion, and loan agreement for Exenatide once-weekly Development, supply, manufacturing, licensing, promotion, and loan agreement for Exenatide once-weekly (terminated)
BY AND BETWEEN AMYLIN PHARMACEUTICALS, INC. AND ELI LILLY AND COMPANY EFFECTIVE AS OF SEPTEMBER 19, 2002Co-Promotion Agreement • November 11th, 2015 • New York
Contract Type FiledNovember 11th, 2015 JurisdictionThis U.S. Co-Promotion Agreement (the "Agreement") is made effective as of the 19th day of September, 2002 (the "Effective Date") by and between Amylin Pharmaceuticals, Inc. ("Amylin"), a Delaware corporation having its principal place of business at 9373 Towne Center Drive, Suite 250, San Diego, California, 92121,